It has been well documented that FRDA patient cells, mouse models and cell models with reduced frataxin levels exhibit increased susceptibility to oxidative stress [21,34,60,see review 67], although the exact mechanism for this effect is yet to be elucidated. This evidence concerns the gene FXN and Friedreich ataxia.